70 studies found for:    Open Studies | "Eye Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Eye Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting MRI in Diagnosing Solid Tumors of the Eye and Orbit
Condition: Eye Cancer
Intervention: Procedure: dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)
2 Recruiting Sentinel Lymph Node (SLN) Biopsy for Sebaceous Gland Carcinoma of Eyelid
Condition: Eye Cancer
Interventions: Procedure: Lymphatic Mapping;   Procedure: SLN Mapping/Biopsy
3 Recruiting Postoperative Pain in Orbital Disease and Ocular Tumor
Condition: Postoperative Pain
Intervention: Procedure: general anesthesia,orbital operation
4 Recruiting Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
Conditions: Neuroblastoma;   Sarcoma;   Carcinoma;   Desmoplastic Small Round Cell Tumor;   Retinoblastoma;   Wilms Tumor;   Melanoma
Intervention:
5 Recruiting Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: Adjuvant chemotherapy by Fotemustin;   Other: Intensive surveillance
6 Recruiting Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Condition: Retinoblastoma
Interventions: Drug: Carboplatin;   Drug: Maxitrol®;   Procedure: Focal Therapy;   Procedure: Plaque Radiotherapy
7 Recruiting Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Conditions: Uveal Melanoma;   Choroid Neoplasm
Intervention: Biological: ICON-1
8 Not yet recruiting Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Selumetinib
9 Not yet recruiting Efficacy Study of Pembrolizumab With Entinostat to Treat Metastatic Melanoma of the Eye
Condition: Metastatic Uveal Melanoma
Interventions: Drug: Pembrolizumab;   Drug: Entinostat
10 Not yet recruiting Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
Conditions: Amblyopia;   Myopia;   Hyperopia;   Astigmatism;   Cataract;   Retinoblastoma;   Trachoma;   Xerophthalmia;   Glaucoma;   Retinopathy of Prematurity
Interventions: Device: Spot photoscreener;   Procedure: Ophthalmologic evaluation;   Procedure: Cyclopleged refraction
11 Recruiting Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: ipilimumab;   Drug: Nivolumab
12 Recruiting PCI Imaging System in Pediatric Ophthalmology
Condition: Retinoblastoma
Interventions: Procedure: Examination under anaesthetic (EUA);   Device: RetCam;   Device: COSMOS
13 Recruiting A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: LXS196
14 Recruiting A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: IMCgp100
15 Recruiting Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma
Conditions: Primary Central Nervous Lymphoma;   Intraocular Lymphoma
Intervention: Drug: Ibrutinib
16 Recruiting MRI and Orbital Tumours (MEDORT)
Conditions: Orbital Tumor;   Orbital Pseudotumor
Intervention: Other: MRI
17 Recruiting Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Conditions: Retinoblastoma;   Clear Cell Sarcoma;   Renal Cell Carcinoma;   Rhabdoid Tumor;   Wilms Tumor;   Hepatoblastoma;   Neuroblastoma;   Germ Cell Tumors;   Ewings Sarcoma;   Non-rhabdomyosarcoma Soft Tissue Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma
Interventions: Drug: Simvastatin;   Drug: Cyclophosphamide;   Drug: Topotecan;   Drug: Myeloid growth factor
18 Recruiting Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma
Conditions: Recurrent Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Drug: Glembatumumab Vedotin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
19 Recruiting Pembrolizumab in Treating Patients With Advanced Uveal Melanoma
Conditions: Stage IIIA Uveal Melanoma;   Stage IIIB Uveal Melanoma;   Stage IIIC Uveal Melanoma;   Stage IV Uveal Melanoma
Interventions: Biological: Pembrolizumab;   Other: Laboratory Biomarker Analysis
20 Recruiting SPT Screening in Irradiated Hereditary Retinoblastoma Survivors
Condition: Retinoblastoma
Intervention: Device: Magnetic resonance imaging

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years